New gene therapy conquers blood cancer – Boston Herald
Boston Herald |
New gene therapy conquers blood cancer
Boston Herald When four rounds of chemotherapy failed to eradicate the cancer running through Judy Wilkins’ veins, her doctor talked her into joining a groundbreaking gene therapy trial at the Dana-Farber Cancer Institute in Boston. “She looked at me and said, ‘Yeah … |
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |